We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Latest News
Agreement to Streamline Drug Development
News

Agreement to Streamline Drug Development

Invitrogen will combine its Voltage Sensor Probes ion channel reagents with PerkinElmer’s CellLux™ Fluorescence Cellular Screening Platform.
Alnylam Grants Qiagen License to Kreutzer-Limmer Patents
News

Alnylam Grants Qiagen License to Kreutzer-Limmer Patents

This patent family, owned by Alnylam, covers small interfering RNAs and their use to mediate RNAi in mammalian cells.
Gene-IT Licenses GenomeQuest™ to Canadian Intellectual Property Office
News

Gene-IT Licenses GenomeQuest™ to Canadian Intellectual Property Office

GenomeQuest™ is a genomic information service and software application that provides sequence comparison solutions for biological and patent investigators.
ISB Adopts Kreatech's ULS™ Nucleic Acid Labeling Technology
News

ISB Adopts Kreatech's ULS™ Nucleic Acid Labeling Technology

ULS™ is now the preferred labeling method for both bacterial gene expression profiling and Chip on Chip assays that have been developed at the ISB.
Positive Beta Site Results for Sequenom's iPLEX™ Assay Trigger Multiple Sales
News

Positive Beta Site Results for Sequenom's iPLEX™ Assay Trigger Multiple Sales

Sequenom's iPLEX assay is very useful for evaluating targeted sets of SNPs and also expedites follow up work in the validation of genome scan results.
Researchers Create Functioning Artificial Proteins
News

Researchers Create Functioning Artificial Proteins

Researchers have discovered a set of simple rules and have now employed these rules to create artificial proteins.
Sareum Collaborates with Infinity Pharmaceuticals
News

Sareum Collaborates with Infinity Pharmaceuticals

Sareum will utilise its skills in high throughput protein expression, purification and structure determination to illustrate the precise nature of how Infinity’s potential drug candidates interact with target receptor proteins.
Discovery of Blood Serum Biomarkers for Breast Cancer
News

Discovery of Blood Serum Biomarkers for Breast Cancer

Power3 Medical Products, Inc. has discovered a group of breast cancer protein biomarkers in preliminary studies of blood serum.
NuGEN Granted Patent for RNA Amplification Technology
News

NuGEN Granted Patent for RNA Amplification Technology

This patent establishes protection around the company's innovative linear, isothermal RNA amplification technology.
Oxford Gene Technology Grants Microarray Licence to Febit
News

Oxford Gene Technology Grants Microarray Licence to Febit

Agreement strengthens febit’s IP and places febit in a position to successfully market Geniom® worldwide.
Advertisement